ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,634.80
      0.80%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.72
      -0.22%
      Bitcoin
      58,875.50
      -2.14%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Emergent Biosolutions Inc (EBS)

      7. Emergent Biosolutions Inc (EBS) News

      EBS

      Emergent Biosolutions (EBS)

      Emergent Biosolutions Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:EBS
      DateTimeSourceHeadlineSymbolCompany
      1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
      09/26/20225:06PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      09/26/20224:12PMGlobeNewswire Inc.Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All AgesNYSE:EBSEmergent Biosolutions Inc
      09/06/20226:30AMGlobeNewswire Inc.Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine CandidateNYSE:EBSEmergent Biosolutions Inc
      08/12/20226:01PMDow Jones NewsFDA Issues Warning Letter to Emergent Biosolutions After February InspectionNYSE:EBSEmergent Biosolutions Inc
      08/12/20225:04PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      08/10/20226:30AMGlobeNewswire Inc.Emergent BioSolutions to Participate in Investor ConferencesNYSE:EBSEmergent Biosolutions Inc
      08/04/20228:12AMTipRanksJ.P. Morgan Reaffirms Their Hold Rating on Emergent Biosolutions (EBS)NYSE:EBSEmergent Biosolutions Inc
      08/03/20226:02AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:EBSEmergent Biosolutions Inc
      08/02/20226:02AMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:EBSEmergent Biosolutions Inc
      08/01/20224:12PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      08/01/20224:05PMGlobeNewswire Inc.Emergent BioSolutions Reports Financial Results for Second Quarter 2022NYSE:EBSEmergent Biosolutions Inc
      07/22/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
      07/18/20224:05PMGlobeNewswire Inc.Emergent BioSolutions to Release Second Quarter 2022 Financial Results and Conduct Conference Call on August 1, 2022NYSE:EBSEmergent Biosolutions Inc
      07/07/20224:30PMGlobeNewswire Inc.Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for EbolaNYSE:EBSEmergent Biosolutions Inc
      07/06/20224:05PMGlobeNewswire Inc.Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of DirectorsNYSE:EBSEmergent Biosolutions Inc
      06/24/20227:13AMDow Jones NewsEmergent BioSolutions: FDA to Review AV7909 Anthrax Vaccine CandidateNYSE:EBSEmergent Biosolutions Inc
      06/24/20226:30AMGlobeNewswire Inc.Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine CandidateNYSE:EBSEmergent Biosolutions Inc
      06/21/20226:30AMGlobeNewswire Inc.Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenicity Data in The Lancet Infectious DiseasesNYSE:EBSEmergent Biosolutions Inc
      06/13/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
      06/07/20226:44AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      06/06/20229:17AMDow Jones NewsEmergent BioSolutions Says Janssen Has Breached Covid Vaccine ContractNYSE:EBSEmergent Biosolutions Inc
      06/06/20228:03AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      06/02/20228:20AMGlobeNewswire Inc.Emergent BioSolutions to Participate in Investor ConferencesNYSE:EBSEmergent Biosolutions Inc
      05/31/20224:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
      05/31/20224:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
      05/31/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
      05/31/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
      05/31/20224:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
      05/25/20224:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
       Showing the most relevant articles for your search:NYSE:EBS